| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| GELFOND RICHARD L | Chief Executive Officer, Director | 902 BROADWAY, 20TH FLOOR, NEW YORK | /s/ Richard L. Gelfond | 12 Mar 2026 | 0000944011 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMAX | common shares | Conversion of derivative security | +121,220 | +16% | $31.40* | 886,222 | 10 Mar 2026 | Direct | F1 | |
| transaction | IMAX | common shares | Sale | $4,860,837 | -121,220 | -14% | $40.10 | 765,002 | 10 Mar 2026 | Direct | |
| holding | IMAX | common shares (opening balance) | 765,002 | 10 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMAX | stock options (to buy) | Conversion of derivative security | -121,220 | -25% | $31.40* | 365,064 | 10 Mar 2026 | common shares | 121,220 | $31.40 | Direct | F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2026. |
| F2 | These options were issued in 2016 and are set to expire on June 7, 2026. |
| F3 | The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. |
| F4 | This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,697,475, 231,562 and 765,002, respectively. |